At a Glance
| 1cP-AL-LAD | DOI | |
|---|---|---|
| Class | Psychedelic | Psychedelic |
| Common Dose (oral) | 100–225 µg | 1–2 mg |
| Total Duration | 3.3–7 hrs | 7.3–14.6 hrs |
| Routes | oral | oral |
| Effects | 72 documented | 66 documented |
Dosage
oral
| Level | 1cP-AL-LAD | DOI |
|---|---|---|
| Threshold | 20 µg | 0.5 mg |
| Light | 50–100 µg | 0.5–1 mg |
| Common | 100–225 µg | 1–2 mg |
| Strong | 225–350 µg | 2–3 mg |
| Heavy | 350 µg | 3 mg |
Duration
oral
1cP-AL-LAD
oral
Total: 7 hrs – 10 hrsPeak
Offset
Afterglow
Onset20 min – 1 hrs
Come Up30 min – 1 hrs
Peak2.5 hrs – 5 hrs
Effects
Safety
Interaction: 1cP-AL-LAD + DOI
No direct interaction data available between these substances. This does not mean the combination is safe.
1cP-AL-LAD — Dangerous Interactions
No dangerous interactions recorded.
DOI — Dangerous Interactions
No dangerous interactions recorded.
Frequently Asked Questions
What is the difference between 1cP-AL-LAD and DOI?
1cP-AL-LAD is classified as a Psychedelic (Lysergamides) while DOI is classified as a Psychedelic (Substituted amphetamines). They share 52 effects in common, with 20 effects unique to 1cP-AL-LAD and 14 unique to DOI.
Is it safe to combine 1cP-AL-LAD and DOI?
There is no direct interaction data available for combining 1cP-AL-LAD and DOI. This does not mean the combination is safe. Always exercise caution and research thoroughly.
Which is stronger, 1cP-AL-LAD or DOI?
At common doses via oral, 1cP-AL-LAD is typically dosed at 100–225 µg while DOI is dosed at 1–2 mg. However, "stronger" depends on context — potency, subjective intensity, and duration all factor in. These substances have different pharmacological profiles and comparing raw potency is not straightforward.